Visioneering Technologies, Inc. (VTI.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.2 Million AUD | 23.04% |
| 2022 | 9.1 Million USD | -38.94% |
| 2021 | 14.91 Million AUD | 199.06% |
| 2020 | 4.98 Million AUD | -14.46% |
| 2019 | 5.83 Million AUD | -43.83% |
| 2018 | 10.37 Million AUD | -49.51% |
| 2017 | 20.55 Million AUD | -34.0% |
| 2016 | 31.14 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.11 Million USD | -20.01% |
| 2024 Q2 | 6.11 Million USD | 0.0% |
| 2023 Q4 | 7.64 Million USD | -35.72% |
| 2023 Q2 | 12.22 Million USD | 0.37% |
| 2023 FY | 11.2 Million AUD | 23.04% |
| 2023 Q1 | 12.17 Million USD | 33.71% |
| 2023 Q3 | 11.89 Million USD | -2.69% |
| 2022 Q2 | 16.79 Million USD | 8.39% |
| 2022 Q4 | 9.1 Million USD | -36.04% |
| 2022 FY | 9.1 Million USD | -38.94% |
| 2022 Q1 | 15.49 Million USD | 3.92% |
| 2022 Q3 | 14.23 Million USD | -15.24% |
| 2021 Q1 | 23.98 Million USD | 270.45% |
| 2021 FY | 14.91 Million AUD | 199.06% |
| 2021 Q4 | 14.91 Million AUD | -27.74% |
| 2021 Q3 | 20.63 Million USD | -15.06% |
| 2021 Q2 | 24.29 Million USD | 1.3% |
| 2020 Q4 | 6.47 Million AUD | -7.05% |
| 2020 FY | 4.98 Million AUD | -14.46% |
| 2020 Q1 | 11.44 Million USD | 96.3% |
| 2020 Q2 | 10.19 Million USD | -10.89% |
| 2020 Q3 | 6.96 Million USD | -31.69% |
| 2019 Q4 | 5.83 Million AUD | -32.51% |
| 2019 FY | 5.83 Million AUD | -43.83% |
| 2019 Q3 | 8.63 Million USD | 30.64% |
| 2019 Q2 | 6.61 Million USD | 1.14% |
| 2019 Q1 | 6.53 Million USD | -37.01% |
| 2018 Q1 | 14.52 Million USD | -29.36% |
| 2018 Q3 | 14.36 Million USD | -4.72% |
| 2018 Q4 | 10.37 Million AUD | -27.72% |
| 2018 FY | 10.37 Million AUD | -49.51% |
| 2018 Q2 | 15.07 Million USD | 3.8% |
| 2017 Q2 | 34.73 Million USD | -0.6% |
| 2017 Q1 | 34.93 Million USD | 192.46% |
| 2017 FY | 20.55 Million AUD | -34.0% |
| 2017 Q4 | 20.55 Million AUD | -21.57% |
| 2017 Q3 | 26.2 Million USD | -24.54% |
| 2016 FY | 31.14 Million AUD | 0.0% |
| 2016 Q4 | 11.94 Million USD | 6.07% |
| 2016 Q3 | 11.26 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 90.663% |
| Adherium Limited | 9.88 Million AUD | -13.333% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 88.995% |
| Atomo Diagnostics Limited | 11.37 Million AUD | 1.526% |
| Anteris Technologies Ltd | 45.7 Million AUD | 75.481% |
| Control Bionics Limited | 9.02 Million AUD | -24.128% |
| CardieX Limited | 12.64 Million AUD | 11.418% |
| Compumedics Limited | 40.35 Million AUD | 72.235% |
| Cochlear Limited | 2.74 Billion AUD | 99.592% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 56.988% |
| Cyclopharm Limited | 45.91 Million AUD | 75.595% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 53.255% |
| Nova Eye Medical Limited | 29.88 Million AUD | 62.501% |
| HeraMED Limited | 2.95 Million AUD | -279.575% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 7.972% |
| ImpediMed Limited | 46.98 Million AUD | 76.152% |
| InhaleRx Limited | 1.57 Million AUD | -610.604% |
| LBT Innovations Limited | 7.93 Million AUD | -41.286% |
| Micro-X Limited | 26.89 Million AUD | 58.337% |
| Neurotech International Limited | 12.21 Million AUD | 8.253% |
| OncoSil Medical Limited | 6.71 Million AUD | -66.787% |
| PolyNovo Limited | 109.16 Million AUD | 89.736% |
| Respiri Limited | 6.19 Million AUD | -80.997% |
| SomnoMed Limited | 69.8 Million AUD | 83.948% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 62.798% |
| Uscom Limited | 5.13 Million AUD | -118.232% |